A comprehensive investigation spearheaded by the University of Cambridge has illuminated a significant association between the menopausal transition and observable changes in brain structure, alongside a heightened prevalence of anxiety, depressive symptoms, and sleep disturbances among women. The research team identified a discernible reduction in grey matter volume within critical cerebral regions in individuals who have undergone menopause. This scientific inquiry, disseminated in the esteemed journal Psychological Medicine, also delved into the impact of hormone replacement therapy (HRT). While HRT did not appear to confer protective benefits against these neurological and psychological shifts, it was found to be linked with a moderated deceleration in the decline of reaction speed.
Menopause represents a pivotal biological milestone in a woman’s life, signifying the definitive cessation of menstrual cycles, a consequence of diminishing ovarian hormone production. Typically commencing between the ages of 45 and 55, this phase is frequently accompanied by a spectrum of somatic and psychological manifestations, including vasomotor symptoms (hot flashes), fluctuations in mood, and disruptions to sleep architecture. Prior scientific endeavors have already posited connections between menopause and alterations in cognitive functions, encompassing memory recall, attentional capacity, and linguistic processing.
To address the management of menopausal symptoms, particularly those impacting mood and sleep quality, HRT is frequently prescribed to women. In England alone, the utilization of HRT saw a notable increase, with 15% of women receiving prescriptions in 2023. Despite its widespread clinical application, a complete understanding of how menopause and HRT exert their influence on the intricate workings of the brain, cognitive faculties, and overall mental well-being remains an evolving area of scientific exploration.
In an effort to comprehensively elucidate these multifaceted effects, researchers undertook an extensive analysis utilizing data sourced from the UK Biobank, encompassing a cohort of nearly 125,000 women. The study participants were meticulously categorized into three distinct groups: women who had not yet experienced menopause, women who were post-menopausal and had never undergone HRT, and women who were post-menopausal and had received HRT.
Participants engaged in the completion of detailed questionnaires designed to capture information regarding menopausal symptoms, psychological health status, established sleep patterns, and general health indices. A subset of these individuals also underwent cognitive assessments designed to evaluate memory capabilities and response times. Furthermore, approximately 11,000 women were subjected to magnetic resonance imaging (MRI) scans, enabling the researchers to meticulously examine structural differences within the brain. The average age at which menopause was attained among the study participants was approximately 49.5 years. Women who were prescribed HRT typically initiated treatment around the age of 49.
The findings revealed that women who had navigated the menopausal transition were statistically more likely to seek professional medical assistance from general practitioners or psychiatrists for concerns related to anxiety, nervousness, or depression, when compared to their pre-menopausal counterparts. They also reported higher scores on validated depression assessment tools and were more frequently prescribed antidepressant medications. Interestingly, women within the HRT group exhibited elevated levels of anxiety and depression when contrasted with women who did not utilize HRT. However, a more granular analysis indicated that these pre-existing differences in mood were evident prior to the onset of menopause. This observation led the researchers to hypothesize that some physicians may have initiated HRT as a preemptive measure, anticipating that the menopausal transition could potentially exacerbate pre-existing mood vulnerabilities.
Sleep disturbances were also found to be a more prevalent concern following menopause. Post-menopausal women were more inclined to report experiences of insomnia, reduced sleep duration, and persistent feelings of fatigue. Notably, women undergoing HRT reported experiencing the greatest degree of fatigue among all three groups, despite no significant differences in their total sleep duration compared to post-menopausal women not taking HRT.
Dr. Christelle Langley, affiliated with the Department of Psychiatry, emphasized the profound impact of menopause, stating, "Most women will experience menopause, and it can be a life-altering event, irrespective of whether they opt for HRT. Maintaining a healthy lifestyle—encompassing regular physical activity, sustained engagement in movement, and adherence to a nutritious diet, for instance—is of paramount importance during this transitional period to help attenuate some of its potential effects. We must cultivate greater sensitivity not only to the physical but also to the psychological well-being of women during menopause, recognizing when they are experiencing difficulties. There should be no inherent stigma associated with openly communicating one’s experiences and seeking necessary support."
The study also identified correlations between menopause and alterations in cognitive performance. Women who were post-menopausal and not receiving HRT demonstrated slower reaction times when compared to both women who had not yet reached menopause and those utilizing HRT. However, memory performance did not exhibit statistically significant variations across the three distinct groups.
Dr. Katharina Zühlsdorff from the Department of Psychology at the University of Cambridge elaborated on these cognitive findings, noting, "As individuals age, there is a natural tendency for reaction times to lengthen; this is an inherent aspect of the aging process, affecting both men and women. One can envision a scenario in a quiz setting where, while the correct answer might still be reached, a younger individual would undoubtedly arrive at it with considerably greater alacrity. Menopause appears to accelerate this inherent physiological process, whereas HRT seems to act as a moderating influence, effectively decelerating this aspect of the aging trajectory to a degree."
Neuroimaging data revealed that post-menopausal women exhibited substantial reductions in grey matter volume, an observation that held true regardless of their HRT status. Grey matter, the primary component of the central nervous system, is comprised of neuronal cell bodies and plays a crucial role in a myriad of cognitive functions, including information processing, the orchestration of motor control, and the intricate regulation of memory and emotional responses. The brain regions most significantly affected by these structural alterations included the hippocampus, a structure vital for the formation and consolidation of memories; the entorhinal cortex, which serves as a critical conduit for information transfer between the hippocampus and other brain regions; and the anterior cingulate cortex, a region integral to emotional regulation, decision-making processes, and the maintenance of focused attention.
Professor Barbara Sahakian, the senior author of the study from the Department of Psychiatry, offered further insight into the potential long-term implications of these findings, suggesting, "The specific brain regions identified as exhibiting these structural differences are precisely those that are characteristically impacted by Alzheimer’s disease. Menopause may, therefore, render these women more susceptible to neurodegenerative conditions later in life. While not a singular determinant, this observation could contribute to understanding the observed phenomenon of nearly twice as many dementia cases occurring in women compared to men."
About the Author
